SerinN1 - FACEIT level 10, 2,229 ELO

Romania
On FACEIT since 2017 71 matches tracked 56 matches in 30 days
ELO ▲ 49
2,229
30-day peak: 2,229
Rank EU
#129,775
Romania #1,554 in Romania
Last updated:

SerinN1 at a glance

Level 10 2,229 ELO best map Ancient (50%)
2,001-2,249 ELO

Last 20 matches compared with 2,998 players in this group: K/R and ADR above average, win rate right on the average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 94%
1.27
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.43 ConsistencyShare of matches with a rating of 0.90 or higher. 85%
K/R
0.89
better than 93% of players
2,001-2,249 ELO avg: 0.74
Last 12 months
ADR
99.2
better than 96% of players
2,001-2,249 ELO avg: 80.8
Last 12 months
Win rate
50%
right on the average
2,001-2,249 ELO avg: 50%
Last 12 months

Facts

71 ELO Next goal ELO to 2,300
9 W · 4 L Best day +101 ELO · Nov 2, 2026
3 Comebacks last 90 days
4 W · 2 L Overtime in overtime
Mirage Favorite map 21 of 71 matches
Ancient 50% Map pool tip weakest: Mirage 43%
1 knife kill Rare kills last 90 days
On Mondays Playing times most active
FormMapsTiming

71 ELO away from 2,300 ELO. 9:4 on Nov 2, 2026 (+101 ELO, last 90 days). 3 wins after trailing at halftime (last 90 days). 6 matches in overtime, 4 of them won (last 90 days). Most played: Mirage (21 of 71 matches). Strongest map: Ancient (50% win rate, 14 matches). Weakest: Mirage (43%, 21 matches). 1 knife kill (last 90 days). Plays most on Mondays (based on 71 matches).

About SerinN1

SerinN1 plays CS2 on FACEIT level 10 with 2,229 ELO. The stats cover 71 matches. The strongest map is Ancient with a 50% win rate in 14 matches. Most played: Mirage with 21 matches and a 43% win rate. Biggest strength: Rounds with first kill at 17%, better than 99% of level 10 · 2,001-2,249 ELO players. SerinN1 won 3 matches after trailing at halftime (last 90 days). Last 20 matches: 10 wins, 10 losses, +101 ELO. Previously known as KafkaN1.